StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — ICICI Securities

BUYCaplin Point Laboratories Limited
Caplin Point Laboratories share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)6 Feb 2026via Institutional / Brokerage Research

Entry₹1,825.7Inferred
Target₹2,155
Total upside +18.04% (call closed)
Stop lossNot given
Exit₹2,1559 Jun 2026, 12:06 pm
Target hit+18.04%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1027 closed calls)Get alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 24 Oct, 12:55 am IST
2 supporting1 neutral0 opposing
Supports the BUY call (2)

Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Ltd, has received final approval from USFDA for Foscarnet Sodium Injection.

BSE · Company Update·14 May · 4w ago

(opens in new tab)
Neutral / worth noting (1)

Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·14 May · 4w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Caplin Point Laboratories

All analyst calls on Caplin Point Laboratories

More from ICICI Securities

Every call and its outcome